Your browser doesn't support javascript.
loading
Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL).
Malfona, Francesco; Testi, Anna Maria; Moleti, Maria Luisa; Petrucci, Luigi; Leccisotti, Lucia; Martelli, Maurizio; Di Rocco, Alice.
Afiliação
  • Malfona F; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Testi AM; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Moleti ML; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Petrucci L; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Leccisotti L; Nuclear Medicine Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome.
  • Martelli M; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Di Rocco A; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Leuk Lymphoma ; 63(2): 483-486, 2022 02.
Article em En | MEDLINE | ID: mdl-34612154
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Linfoma Difuso de Grandes Células B / Neoplasias do Sistema Nervoso Central / Linfoma / Neoplasias do Mediastino Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Linfoma Difuso de Grandes Células B / Neoplasias do Sistema Nervoso Central / Linfoma / Neoplasias do Mediastino Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article